The First Inter-Country Meeting on Designing and Implementing a Regulatory Program for Medical Devices (Provisional Program) was conducted in Riyadh, Saudi Arabia, 11-14 April 2016.
The meeting was attended by MOH officials /regulators from 22 countries within WHO’s EMRO region.
Over 25 Mecomed Regulatory Committee members were privileged to participate in this important event with a lead of Rami Rajab, Mecomed Chairman.
Our colleagues Petra Kaars-Wiele from Abbott and Ojas Zatakia from Philips presented the industry perspectives on pre and post market regulatory controls of medical devices. The presentations were well received by the audience and lead to interactive discussion sessions.
MECOMED’s initiatives were welcomed by the organizers and received a special mention by SFDA and WHO heads.
Meeting Objectives were:
• To offer guidance on design and implementation of effective national programs for MD regulation;
• To share country experiences on models used for MD regulatory functions;
• To develop roadmap, based on step-wise approach to implement MD regulatory controls, for countries at different stages of development.
The Conference began with an opening by Prof. Mohammed Almeshal, CEO, SFDA, followed by a message from Dr Ala Alwan, Regional Director, WHO/EMRO. Other key speakers included Dr. Marthe Everard from Essential Medicines and Health Technologies Team (EMT), WHO/EMRO,
Dr Adham Ismail, WHO/EMRO and Dr. Nazeeh AI-Othmany, VP medical devices, SFDA.
Mecomed will continue its efforts on collaborating with authorities and healthcare officials on the regulatory requirements, so to enhance patient access to cutting-edge therapies across MENA.